Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Review Article Volume 3 Issue 6

Biodegradable Polymeric Nanoparticles for Photodynamic Laser Cancer Therapy

Mohammadreza Saboktakin*

Professor, Nanomedicine Department, NanoBMat Company GmbH, Düsseldorf, Germany

*Corresponding Author: Mohammadreza Saboktakin, Professor, Nanomedicine Department, NanoBMat Company GmbH, Düsseldorf, Germany.

Received: April 08, 2021; Published: May 11, 2021


  Photodynamic cancer therapy is well known and recognized in many countries best therapy for cancer therapy. However, previous findings on PDT are limited to Tumors on the body surface, since the available photosensitizers largely from Porphyrin exist and can only be stimulated with red laser light. The penetration depth of the red laser with effective stimulation of the photosensitizer is about 1 - 2 cm and also limited to a tumor size of about 1 cm. The penetration into the liver or through bone is almost impossible, so that there is no possibility. To successfully treat liver metastases or brain tumors. Infrared laser beams penetrate a lot deeper into the body and can even penetrate liver and bone. A perfect one Photosensitizer should therefore have an absorption spectrum in the infrared range, in the market however, nothing is available. The new polymeric systems have reviewed in this review.

Keywords: Liver; Bone; Cancer Therapy; Nanoparticles


  1. Mohammad Reza Saboktakina., et al. “Synthesis and in vitro studies of biodegradable modified chitosan nanoparticles for photodynamic treatment of cancer”. International Journal of Biological Macromolecules 49 (2011) 1059-1065.
  2. Mohammad Reza Saboktakin., et al. “Intelligent Drug Delivery Systems Based on Modified Chitosan Nanoparticles”. Letters in Organic Chemistry 9 (2012): 56-70.
  3. Ryan F Donnelly., et al. “Drug Delivery Systems for Photodynamic Therapy”. Recent Patents on Drug Delivery and Formulation 3 (2009): 1-7.
  4. Huiying Ding., et al. “Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX”. Journal of Controlled Release 151 (2011): 271-277.
  5. Faina Nakonechny., et al. “New techniques in antimicrobial photodynamic therapy: scope of application and overcoming drug resistance in nosocomial infections”. Science against microbial pathogens: communicating current research and technological advances Méndez-Vilas (Ed.) (2011).
  6. Hamanou Benachour., et al. “Multifunctional Peptide-Conjugated Hybrid Silica Nanoparticles for Photodynamic Therapy and MRI”. Theranostics9 (2012): 889-904.
  7. Shizhong Wang., et al. “Nanomaterials and singlet oxygen photosensitizers: potentialapplications in photodynamic therapy”. Journal of Materials Chemistry 14 (2004): 487-493.
  8. Ayman Khdair., et al. “Surfactant-Polymer Nanoparticles Enhance the Effectiveness of Anticancer Photodynamic Therapy”. Molecular Pharmaceutics 5.5 (2008): 807.
  9. Baris Ungun., et al. “Nanofabricated upconversion nanoparticles for photodynamic therapy”. Optics Express1 (2009): 80.
  10. Huiying Ding., et al. “Photoactivation switch from type II to type I reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxia”. Journal of Controlled Release3 (2011): 276-280.
  11. Huiying Ding., et al. “Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX”. Journal of Controlled Release 151 (2011): 271-277.
  12. Mohammad Reza Saboktakina., et al. “Synthesis and Characterization of Modified Starch Hydrogels for Photodynamic Treatment of Cancer”. International Journal of Biological Macromolecules 51 (2012): 544-549.
  13. João PauloFigueiró Longo., et al. “Nanostructured Carriers for Photodynamic Therapy Applications in microbiology”. Science against microbial pathogens: communicating current research and technological advances Méndez-Vilas (Ed.).
  14. So Jin Lee., et al. “Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice”. Biomaterials 30 (2009): 2929-2939.
  15. Prakash Rai., et al. “Nanotechnology-based combination therapy improves treatment response in cancer models”. Proc. of SPIE (2009).
  16. Maryam Bakhshizadeh., et al. “Effects of Combined Sonodynamic and Photodynamic Therapies on a Colon Carcinoma Tumor Model”. Iranian Journal of Basic Medical Sciences 3 (2011).
  17. Anurag Gupta., et al. “Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles”. Nanomedicine: Nanotechnology, Biology, and Medicine 8 (2012): 941-950.
  18. Maheshika Kuruppuarachchi., et al. “Polyacrylamide Nanoparticles as a Delivery System in Photodynamic Therapy”. Molecular Pharmaceutics3 (2011): 920-931.
  19. J Kopecˇeka., et al. “Water soluble polymers in tumor targeted delivery”. Journal of Controlled Release 74 (2001): 147-158.
  20. Maria C., et al. “Photosensitized singlet oxygen and its applications”. Coordination Chemistry Reviews 233/234 (2002): 351-371.
  21. So Jin Lee., et al. “Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system”. Biomaterials 32 (2011): 4021e4029.
  22. Xueheng Cheng., et al. “Using Electrospray Ionization FTICR Mass Spectrometry To Study Competitive Binding of Inhibitors to Carbonic Anhydrase”. Journal of the American Chemical Society 117 (1995): 8859-8860.
  23. Yong-Eun Lee., et al. “Brain cancer diagnosis and therapy with nanoplatforms”. Advanced Drug Delivery Reviews 58 (2006): 1556-1577.
  24. Niraj B Patel. “Targeted methylene blue-containing polymeric nanoparticle formulations for oral antimicrobial photodynamic therapy”. (2009).
  25. Boseung Jang and Yongdoo Choi. “Photosensitizer-Conjugated Gold Nanorods for Enzyme-Activatable Fluo-rescence Imaging and Photodynamic Therapy”. Theranostics 2 (2012): 190-197.
  26. Youngnam Cho., et al. “Chitosan nanoparticle based neuronal membrane sealing and neuroprotection following acrolein induced cell injury”. Journal of Biological Engineering 4 (2010): 2.
  27. Wagner V., et al. “The emerging nanomedicine landscape”. Nature Biotechnology10 (2006): 1211-1218.
  28. Kim BY., et al. “Nanomedicine”. The New England Journal of Medicine 25 (2010): 2434-2443 (2010).
  29. Jacobson GB., et al. “Biodegradable nanoparticles with sustained release of functional siRNA in skin”. Journal of Pharmaceutical Sciences 10 (2010): 4261-4266.
  30. O’Brien ME., et al. “Reduced cardiotoxicity and comparable efficacy in a Phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer”. Annals of Oncology3 (2004): 440-449.
  31. Davis ME., et al. “Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles”. Nature 7291 (2010): 1067-1070.
  32. Scranton R and Cincotta A. “Bromocriptine - unique formulation of a dopamine agonist for the treatment of Type 2 diabetes”. Expert Opinion on Pharmacotherapy2 (2010): 269-279.
  33. Lim WT., et al. “Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors”. Annals of Oncology 2 (2009): 382-388.
  34. Winter PM., et al. “Molecular imaging of angiogenesis in early-stage atherosclerosis with avb3-integrin-targeted nanoparticles”. Circulation18 (2003): 2270-2274.
  35. Keren S., et al. “Noninvasive molecular imaging of small living subjects using Raman spectroscopy”. Proceedings of the National Academy of Sciences of the United States of America 15 (2008): 5844-5849.
  36. Jain PK., et al. “Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine”. Accounts of Chemical Research 12 (2008): 1578-1586.
  37. Maeda H., et al. “Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review”. Journal of Control Release1-2 (2000): 271-284.
  38. Knop K., et al. “Poly (ethylene glycol) in drug delivery: pros and cons as well as potential alternatives”. Angewandte Chemie 36 (2006): 6288-6308.
  39. van Vlerken LE., et al. “Poly (ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery”. Pharmaceutical Research8 (2007): 1405-1414.
  40. Kanaras AG., et al. “Thioalkylated tetraethylene glycol: a new ligand for water soluble monolayer protected gold clusters”. Chemical Communication 20 (2002): 2294-2295.


Citation: Mohammadreza Saboktakin. “Biodegradable Polymeric Nanoparticles for Photodynamic Laser Cancer Therapy”. Acta Scientific Women's Health 3.6 (2021): 11-22.


Copyright: © 2021 Mohammadreza Saboktakin. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

Contact US